HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!


Delivering pathogen testing at the speed of software with one test for all pathogens.


Mridu Sinha


Company details

More info on the IndieBio website

Melio is breaking the one-pathogen one-probe paradigm in diagnostics to deliver the unmet holy grail for pathogen testing for bloodstream infections. Melio delivers diagnostic capabilities that is scalable “over the air” with a few universal probes, without making any changes to hardware. We read each pathogen cell in the blood by how its DNA unwinds, melts or denatures. Melio is disrupting the century-old paradigm of slow and inefficient pathogen testing. First, we are bring our product to vulnerable newborn population, where, for the lack of better diagnostics, 150 babies are given antibiotics for every 1 that truly needs it.

Get In Touch with Melio

Please tell us a little bit about yourself and why you'd like to get connected. Melio + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.